Lung cancer is the leading cause of cancer-related death worldwide. However, lung cancer
incidence and mortality rates differ substantially across the world, reflecting varying patterns …

Randomised controlled trials, including the National Lung Screening Trial (NLST) and the
NELSON trial, have shown reduced mortality with lung cancer screening with low-dose CT …

Lung cancer is the leading cause of mortality and person-years of life lost from cancer
among US men and women. Early detection has been shown to be associated with reduced …

Importance Lung cancer is the leading cause of cancer-related death in the US. Objective To
review the evidence on screening for lung cancer with low-dose computed tomography …

In the past decade, the introduction of molecularly targeted agents and immune-checkpoint
inhibitors has led to improved survival outcomes for patients with advanced-stage lung …

肺癌是中国发病率和死亡率最高的恶性肿瘤. 筛查与早诊早治是降低人群肺癌死亡率的有效措施
. 制定符合中国国情的肺癌筛查与早诊早治指南, 将极大推进中国肺癌筛查的同质性和优质性 …

Importance Cancer screening tests are promoted to save life by increasing longevity, but it is
unknown whether people will live longer with commonly used cancer screening tests …

Background Lung cancer is the leading cause of cancer death worldwide. Data on the
effectiveness of one-off low-dose CT (LDCT) in reducing lung cancer mortality and all-cause …

ABSTRACT Background The National Lung Screening Trial showed that lung cancer (LC)
screening by three annual rounds of low-dose computed tomography (LDCT) reduces LC …

In 2011, the US National Lung Cancer Screening Trial (NLST) reported a 20% reduction of
lung cancer mortality after regular screening by low‐dose computed tomography (LDCT), as …